报告题目 | 医疗大数据如何赋能医药临床科研 | ||
报告人（单位） | Lin Zhang，Monash University | ||
点评人（单位） | 王海燕，东南大学 | 点评人（单位） | 孙胜楠，东南大学 |
时间地点 | 2024年3月4日14:00，九龙湖校区经管楼B203（科研中心） | ||
报告简介： 大数据已经成为人类赖以生存的生产资料不断的带来科技进步和融入我们的生活。与此同时，医疗大数据业已成为医药研发和临床诊疗提升的有力工具，用于产生证据来支持医疗产业的飞速进步和发展。 报告人将就其在医疗大数据领域的洞见和思考，从“什么是医疗大数据、数据的治理和标准化、真实世界数据和研究、真实世界临床研究案例”等领域，来分享其在药物研发和临床科研过程中的作用及其商业价值。 | |||
报告人简介：
Lin is currently the Research Fellow/Lectuer of Monash Suzhou Research Institute, Monash University and The School of Public Health and Preventive Medicine, Monash University. Lin has obtained the Medical Degree (MD) from Anhui Medical University, Master of Medicine(MMed) and Master of Public Health(MPH) from Peking Union Medical College/Tsinghua University, Master of Public Administration (MPA) in Chinese Academy of Governance and and Ph.D of Cancer Epidemiology from Melbourne School of Population and Global Health, the University of Melbourne. Lin was a Visiting Research Scientist in Monash University eResearch Centre and Erasmus University Medical Center. Lin’s research team was awarded the “2017 Award for Excellence” of the University of Melbourne. Because of excellent research outcome during in PhD, Lin was awarded the Victorian International Education Award by the Victorian State Government of Australia, and Global Outstanding Graduate by Ministry of Education of China in 2020, and 2022 Winner of Award for Research and Science in Australia China Alumni Association. With 13 years of experience in the clinical medicine, public health, pharmaceutical research, Lin worked as Attending Physician in Peking Union Medical College Hospital, Research Assistant in Victorian Comprehensive Cancer Centre/PeterMac Cancer Hospital and Teaching Assistant for Master of Public Health students in University of Melbourne, and Senior Medical Advisor in Sienna Cancer Diagnostics, Senior Research Scientist in Eli Lilly and Company. Currently, Lin was the General Manager and Chief Medical Officer of Ningbo Branch of Wondersgroup.
Lin has 159 publications (H index=23, Citation=2000) in medical and public health field, and 105 publications on international journals, including BMJ, Lancet, Lancet Haematol, Lancet Digital Health, Lancet Rheumatology, Nature Communication, Gastroenterology, Gut, Frontier in Oncology, etc. Published 2 co-authored books (including The Book of OHDSI：Observational Health Data Sciences and Informatics), and the co-author of 3 books of clinical practice. Lin is the member of the Global Burden of Disease (GBD) Collaborator Network and served as the Associate Editor of a special topic of Frontiers in Pharmacology, and compiled international publication related to PD-1/PD-L1 in cancer treatment. Lin also served as PhD Supervisor in the Artificial Intelligence Research Group of Monash University, and a visiting professor at the University of Science and Technology of China. | |||
